BUDGET CAPACITY OF UKRAINE FOR FINANCING OF COVID-19 VACCINATION IN THE EMERGING GLOBAL VACCINE MARKET

Abstract

The budgetary opportunities of Ukraine for vaccination against COVID-19 in the conditions of formation of a new global market of vaccines are estimated. The principles of the current stage of formation of the global market of vaccines against COVID-19 are revealed. The preconditions for the formation of a global shortage of vaccines against COVID-19, which are caused primarily by the limitations and global shortage of production capacity of vaccines and the shortage of raw materials and components for their production. The factors of formation of the pricing policy in the modern global market of vaccines against COVID-19 are revealed, the main of which are: uncertainty and a wide range of the prices for vaccines established by manufacturers; high level of competition between vaccine manufacturers and the struggle to capture a larger segment of the global market; fierce competition between states for access to potentially required doses of vaccines. There is a gap in access to COVID-19 vaccines in developed and developing countries, which deepens inequality between them in terms of post-pandemic economic recovery. Emphasis is placed on the fact that slow and uneven vaccination against COVID-19 causes GDP losses in both developed and developing countries. One of the approaches of international institutions, the application of which in practice can help to overcome the global shortage of vaccines and stimulate their production, namely the temporary waiver of protection of intellectual property and patents for vaccines against COVID-19, is examine. The need to increase budgetary opportunities for vaccination against COVID-19 in Ukraine in order to achieve collective immunity and protect different groups of the population is proved.